AsclepiusAI keeps cancer patients and their care teams connected between visits — so problems are caught early, understood clearly, and treated before they become emergencies.
The cost of silence between visits
The Problem
Patients are seen for minutes at a time, weeks apart. What happens in between — escalating symptoms, missed doses, unanswered questions — goes unseen until the only option left is the ER.
Issues that a phone call could have managed at home grow silently until they end in an emergency room — and roughly one in four of those visits ends in an unplanned hospitalization.
3.21M preventable ED visits in 2019 aloneOncology inbox volume rose 19% and patient messages rose 34% in three years. Only 5.6% of U.S. oncologists practice in rural areas where the need is greatest.
After-hours EHR work at record highsHalf of patients on oral cancer therapies don't take their medication as prescribed — driven by side effects, confusion, and cost. Nonadherence is directly linked to progression and premature death.
~50% oral therapy nonadherenceThe Platform
A patient-first platform that turns the quiet time between visits into structured, actionable care — light enough for a small clinic to adopt in weeks.
AMI · Artificial Medical Intelligence
PRO Monitor
Every interaction deepens the platform's understanding of each patient. Better intelligence enables earlier intervention — and earlier intervention is everything in oncology.
Meet AMI
Patients forget 40–80% of what they're told in appointments. AMI is there at 2 a.m. when the question actually comes up — answering in plain language, watching for warning signs, and turning worry into a structured report a clinician can act on.
The Evidence
Between-visit symptom reporting has been proven in landmark randomized trials — AsclepiusAI adds the engagement layer those systems lacked.
longer median survival for patients who reported symptoms electronically between visits
Basch et al., JAMA 2017emergency visits across 52 community oncology practices in the national PRO-TECT trial
Basch et al., 2025saved per patient per month — nearly 10% of total cost — driven by 39% fewer hospitalizations
Texas Two-Step, JCO OP 2023of patients reported better communication with their care team
PRO-TECT, 2025Who Benefits
Confidence between visits
When the scary question comes up, AMI answers — accurately, instantly, kindly.
Capacity without headcount
From signature to go-live. No EHR customization project. No integration team.
Lower total cost of care
Total cost of care in a deployed Medicare oncology population.
Built to Pay for Itself
Medicare and commercial payers already reimburse remote patient monitoring and care-management work. AsclepiusAI's outputs — symptom reports, monitoring records, time tracking, escalation documentation — are generated to meet those reimbursement requirements from day one.
For Investors
We're building two compounding assets: a patient engagement platform that lowers cost of care, and a proprietary longitudinal oncology dataset that grows more valuable with every patient enrolled.
Beachhead Market
$20M–$120M SAM
300–600 Midwest rural & community oncology clinics — high need, operationally strained, overlooked by competitors.
Expansion
$500M–$2B+
5,000–8,000 community oncology clinics nationally — same pain points, at scale, with a trained clinical intelligence layer competitors can't replicate.
Comparables
$1.9B · $18.5B
Flatiron Health → Roche (oncology real-world data). Livongo → Teladoc (engagement at scale). Oncology is the larger, more expensive problem.
Join Us
Be among the first clinics and partners to bring evidence-backed, patient-first oncology engagement to the communities that need it most.